Loading clinical trials...

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT01484704

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer. 100 women with newly diagnosed breast cancer will participate the study.

Lead sponsor: Turku University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Nina M Brück, MD

CONTACT

+35823130544 [email protected]

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100

Start dateFeb 2011

Last updatedDec 2, 2011

Condition

Mammary Ductal Carcinoma

Locations shown

University hospital of Turku

Turku

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 2, 2011Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions